These residents won second place at the Eyecelerator competition held prior to this month’s American Academy of Ophthalmology ...

According to the company, Duravyu 2.7mg demonstrated an early and sustained anatomical improvement mirroring BCVA results with a 68 micron reduction in CST. Full topline data is anticipated in Q1 of ...

Chronic therapy is essential for PCV patients, even after resolution of pigment epithelial detachment, to prevent recurrence. Faricimab and aflibercept show efficacy in DME, RVO, and nAMD, but not all ...

Vikas Chopra, MD, led a course on minimally invasive glaucoma surgery (MIGS) and its impact on glaucoma care. He explained that MIGS enables ophthalmologists to intervene earlier and more safely, ...

CBNS, such as turmeric, are natural anti-inflammatory and antioxidant agents that may confer benefits against AMD.

Brian Francis, MD, from the Doheny Eye Institute and the UCLA Department of Ophthalmology, shared insights on MIGS techniques ...

Jonathan Brugger, MD, shared insights on the correlation of central retinal vein occlusions, or branch retinal vein ...

Acknowledging complex dynamics is an important part of traveling abroad as a doctor, according to University of Colorado ...

According to the company, its data replicate and expand upon the potential of ER-100 to improve retinal ganglion cell ...

According to OKYO Pharma, OK-101 is the first drug candidate to enroll patients specifically diagnosed with neuropathic ...

The company will seek a strategic partner to continue development of APX3330, an oral small-molecule inhibitor of Ref-1 for ...

Weijie Violet Lin, MD, presented findings from her research, which revealed that post-cross-linking complications were low ...